Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
NCT06032572 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 204
Last updated 2023-09-13
Summary
The objective of this study is to evaluate the safety and effectiveness of the clinical and technical performance of the VRS100 system with disposable surgical kit in the delivery and manipulation of coronary guidewires and stent/balloon systems for use in percutaneous coronary interventions (PCI).
Conditions
- Coronary Artery Disease
- Cardiovascular Diseases
- Coronary Disease
- Myocardial Ischemia
- Arteriosclerosis
- Vascular Disease Occlusive
Interventions
- PROCEDURE
-
VRS100 robotic-assisted PCI
The VRS100 is intended for use in the remote delivery and manipulation of guidewires and rapid exchange balloon/stent catheters, and remote manipulation of guide catheters during percutaneous coronary intervention (PCI) procedures.
- PROCEDURE
-
Manual PCI
Use the traditional technique of manually advancing intracoronary guidewires, balloons, and stents at the patient's tableside.
Sponsors & Collaborators
-
Shanghai Zhongshan Hospital
collaborator OTHER -
West China Hospital
collaborator OTHER -
Shenzhen People's Hospital
collaborator OTHER -
Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Junbo Ge · Shanghai Zhongshan Hospital
-
Yong He · West China Hospital
-
Da Yin · Shenzhen People's Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-08
- Primary Completion
- 2024-08-01
- Completion
- 2024-08-01
Countries
- China
Study Locations
More Related Trials
-
HELIOS China Registry: Evaluation of the HELIOS Stent in a 'Real-World' Patient Population
NCT03916432 ·Status: RECRUITING ·Phase: NA
-
A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions
NCT01760083 ·Status: COMPLETED ·Phase: NA
-
Brazil Xience V Everolimus-Eluting Coronary Stent System "Real-World" Outcomes Registry
NCT00989066 ·Status: COMPLETED
-
OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation
NCT02504307 ·Status: COMPLETED ·Phase: PHASE4
-
Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence Tomography
NCT01230723 ·Status: UNKNOWN ·Phase: PHASE4
-
Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents
NCT03507205 ·Status: COMPLETED
-
RESOLUTE China Registry:
NCT01243749 ·Status: COMPLETED
-
Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4
NCT01632371 ·Status: COMPLETED ·Phase: PHASE4
-
MagicTouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary Lesions
NCT02400632 ·Status: COMPLETED ·Phase: PHASE3
-
Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis
NCT02197559 ·Status: COMPLETED
-
Absorb Bioresorbable Scaffold vs. Drug Coated Balloon for Treatment Of In-Stent-Restenosis
NCT03529006 ·Status: UNKNOWN ·Phase: NA
-
GENOSS Coronary Stent Clinical Trial
NCT05444452 ·Status: RECRUITING ·Phase: NA
-
Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)
NCT02452736 ·Status: COMPLETED ·Phase: PHASE3
-
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
NCT04893291 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)
NCT06086496 ·Status: ENROLLING_BY_INVITATION
-
Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent
NCT00960908 ·Status: UNKNOWN
-
OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure
NCT06919562 ·Status: RECRUITING
-
Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.
NCT06214819 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery
NCT00731237 ·Status: COMPLETED
-
New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )
NCT01365572 ·Status: UNKNOWN ·Phase: PHASE4
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
NCT05908331 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease
NCT04825886 ·Status: COMPLETED
-
A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary In-stent Restenosis
NCT03373695 ·Status: COMPLETED ·Phase: NA
-
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
NCT02579031 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary Artery Stenosis (PRE-COMBAT 2)
NCT01348022 ·Status: COMPLETED